Latest Videos |view all videos
A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk of poorer survival rate following prostate cancer treatment compared with other minority groups.
Unique laboratory testing during breast cancer lumpectomies to make sure surgeons removed all the cancerous tissue spares patients the need for a repeat operation in roughly 96 percent of cases at Mayo Clinic in Rochester, Minnesota.
A clinical trial co-led by Mayo Clinic Cancer Center researchers found that adding chemotherapy following radiation treatment improved survival for adults with low-grade gliomas by more than five years.
Needle-guided tumor destruction procedures offer near-equivalent lengths of local cancer control compared with surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.
Mayo Clinic researchers help to shine new light on bladder cancer tumors.
Mayo Clinic geriatric psychiatrist Maria I. Lapid, M.D., discusses a study developed by the Mayo Clinic Psycho-Oncology Research Group to improve quality of life of advanced cancer patients.
Interrupting the blood flow for more than 20 to 25 minutes during kidney cancer surgery leads to a greater risk for patients developing chronic kidney disease
The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer.
Amir Lerman, M.D., and Joerg Herrman, M.D., discuss the emerging field of cardioncology that is developing as oncology patients live longer and possible treatment approaches.
Judy C. Boughey, M.D., presents Less Invasive Axillary Surgery after Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071.
The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.
Mayo Clinic has integrated production, imaging and pathology facilities to provide the benefit of Choline C 11 PET imaging to prostate cancer patients.